Charles River Laboratories International (CRL) Divestments (2010 - 2026)
Charles River Laboratories International (CRL) posted Divestments of $116.5 million for Q2 2026, up 93.8% on a QoQ basis from $60.1 million in Q1 2026.
Powered by 
Analysis
Charles River Laboratories International (CRL) Divestments (2010 - 2026) Analysis & Trends
Charles River Laboratories International has reported Divestments for 4 years, with the latest figure at $116.5 million in Q2 2026.
- On a quarterly basis, Divestments changed N/A year-over-year to $116.5 million in Q2 2026; TTM through Jun 2026 was $176.6 million, a 912.34% increase from a year earlier, with the FY2025 full-year figure at $17.4 million, changed N/A from the prior year.
- Divestments was $116.5 million for Q2 2026 at Charles River Laboratories International, up from $60.1 million in the prior quarter.
- The five-year high for Divestments was $116.5 million in Q2 2026, with the low at $17.4 million in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -14.88 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 116.47 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 116.47 Mn |
| Mar 28, 2026 | 60.10 Mn |
| Mar 29, 2025 | 17.44 Mn |
| Apr 1, 2017 | 72.46 Mn |
| Dec 25, 2010 | 8,000.00 |
| Sep 25, 2010 | 5,000.00 |
| Jun 26, 2010 | 961,000.00 |
| Mar 27, 2010 | 1.83 Mn |